Open Access

HFpEF management: state of the art novel devices.

Congress Session

About the speaker

Professor David Kaye

The Alfred Hospital, Melbourne (Australia)
2 presentations
0 follower

4 more presentations in this session

HFpEF management: state of the art neurohumoral modulation.

Speaker: Professor S. Solomon (Boston, US)

Thumbnail

HFpEF management: state of the art SGLT2 inhibitors.

Speaker: Professor R. De Boer (Groningen, NL)

Thumbnail

How-To manage HFpEF: state of the art in 2021 – discussion.

Thumbnail

How-To manage HFpEF: state of the art in 2021 - Chat Moderator.

Thumbnail

Access the full session

How-To manage HFpEF: state of the art in 2021

Speakers: Professor D. Kaye, Professor S. Solomon, Professor R. De Boer
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

New recommendations for comorbidities.

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

Transcatheter treatment for degenerative mitral regurgitation

27 August 2021

This platform is supported by

logo Novo Nordisk